Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of Lung Cancer Brain Metastases to Stereotactic Radiosurgery.
about
Early Post-treatment Assessment of MRI Perfusion Biomarkers Can Predict Long-term Response of Lung Cancer Brain Metastases to Stereotactic Radiosurgery.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@en
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@nl
type
label
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@en
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@nl
prefLabel
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@en
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@nl
P2093
P2860
P356
P1433
P1476
Early Post-treatment Assessmen ...... to Stereotactic Radiosurgery.
@en
P2093
Amita Shukla-Dave
Andrei Holodny
Behroze Vachha
Jung Hun Oh
Kathryn Beal
Neil K Taunk
P2860
P356
10.1093/NEUONC/NOX159
P577
2017-08-24T00:00:00Z